Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-22-061178

Chief Development Officer sold 19,711 shares at an average $18.26 ($359,973)

  • Chief Development Officer acquired 19,711 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Curley Joanne · Chief Development Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2022-12-12 Exercise or conversion : show line 1 in the form +6,900 $11.00 $75,900 33,721 D
2022-12-12 Sale : show line 2 in the form −6,900 $18.25 $125,924 26,821 D
2022-12-13 Exercise or conversion : show line 3 in the form +11,733 $11.00 $129,063 38,554 D
2022-12-13 Sale : show line 4 in the form −11,733 $18.28 $214,441 26,821 D
2022-12-13 Exercise or conversion : show line 5 in the form +1,078 $6.37 $6,870 27,899 D
2022-12-13 Sale : show line 6 in the form −1,078 $18.19 $19,609 26,821 D
Open-market sales · 19,711 sh · avg $18.26 · $359,973

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2022-12-12 Exercise or conversion : show line 7 in the form Stock Options (right to buy) −6,900 77,117 D
2022-12-13 Exercise or conversion : show line 8 in the form Stock Option (right to buy) −11,733 65,384 D
2022-12-13 Exercise or conversion : show line 9 in the form Stock Options (right to buy) −1,078 8,639 D
Loading xslF345X03/doc4.xml…